0 XP   0   0   0

GSK plc










Financial Health of GSK plc




Comparing to competitors in the Other industry




  Industry Rankings  


Richest
#23 / 452

Total Sales
#19 / 452

Making Money
#18 / 452

Working Efficiently
#130 / 452

GSK plc
Buy, Hold or Sell?

Should you buy, hold or sell GSK plc?

I guess you are interested in GSK plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse GSK plc

Let's start. I'm going to help you getting a better view of GSK plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is GSK plc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how GSK plc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value GSK plc. The closing price on 2022-10-10 was €15.53 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
GSK plc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of GSK plc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit GSK plc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare GSK plc to the Other industry mean.
  • A Net Profit Margin of 12.1% means that €0.12 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of GSK plc:

  • The MRQ is 12.1%. The company is making a huge profit. +2
  • The TTM is 12.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.1%TTM12.8%-0.7%
TTM12.8%YOY13.5%-0.6%
TTM12.8%5Y14.7%-1.9%
5Y14.7%10Y14.7%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ12.1%8.2%+3.9%
TTM12.8%7.4%+5.4%
YOY13.5%7.3%+6.2%
5Y14.7%6.7%+8.0%
10Y14.7%6.6%+8.1%
1.1.2. Return on Assets

Shows how efficient GSK plc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare GSK plc to the Other industry mean.
  • 0.9% Return on Assets means that GSK plc generated €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of GSK plc:

  • The MRQ is 0.9%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.9%TTM1.3%-0.4%
TTM1.3%YOY1.4%0.0%
TTM1.3%5Y1.6%-0.2%
5Y1.6%10Y1.6%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9%1.0%-0.1%
TTM1.3%1.0%+0.3%
YOY1.4%0.9%+0.5%
5Y1.6%0.9%+0.7%
10Y1.6%0.9%+0.7%
1.1.3. Return on Equity

Shows how efficient GSK plc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare GSK plc to the Other industry mean.
  • 5.1% Return on Equity means GSK plc generated €0.05 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of GSK plc:

  • The MRQ is 5.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.1%TTM7.2%-2.1%
TTM7.2%YOY7.4%-0.2%
TTM7.2%5Y11.4%-4.2%
5Y11.4%10Y11.4%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1%3.1%+2.0%
TTM7.2%2.9%+4.3%
YOY7.4%2.6%+4.8%
5Y11.4%2.4%+9.0%
10Y11.4%2.4%+9.0%

1.2. Operating Efficiency of GSK plc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient GSK plc is operating .

  • Measures how much profit GSK plc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare GSK plc to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of GSK plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY17.9%-17.9%
TTM-5Y17.7%-17.7%
5Y17.7%10Y17.7%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.1%-17.1%
TTM-9.1%-9.1%
YOY17.9%9.2%+8.7%
5Y17.7%8.5%+9.2%
10Y17.7%8.5%+9.2%
1.2.2. Operating Ratio

Measures how efficient GSK plc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 1.16 means that the operating costs are €1.16 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of GSK plc:

  • The MRQ is 1.158. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.149. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.158TTM1.149+0.009
TTM1.149YOY1.188-0.039
TTM1.1495Y1.165-0.017
5Y1.16510Y1.1650.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1581.218-0.060
TTM1.1491.189-0.040
YOY1.1881.203-0.015
5Y1.1651.289-0.124
10Y1.1651.314-0.149

1.3. Liquidity of GSK plc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if GSK plc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 1.43 means the company has €1.43 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of GSK plc:

  • The MRQ is 1.432. The company is just able to pay all its short-term debts.
  • The TTM is 1.057. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.432TTM1.057+0.375
TTM1.057YOY0.886+0.171
TTM1.0575Y0.904+0.153
5Y0.90410Y0.9040.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4321.491-0.059
TTM1.0571.465-0.408
YOY0.8861.475-0.589
5Y0.9041.299-0.395
10Y0.9041.286-0.382
1.3.2. Quick Ratio

Measures if GSK plc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare GSK plc to the Other industry mean.
  • A Quick Ratio of 0.17 means the company can pay off €0.17 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of GSK plc:

  • The MRQ is 0.172. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.313. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.172TTM0.313-0.140
TTM0.313YOY0.315-0.002
TTM0.3135Y0.304+0.009
5Y0.30410Y0.3040.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1720.612-0.440
TTM0.3130.602-0.289
YOY0.3150.600-0.285
5Y0.3040.563-0.259
10Y0.3040.552-0.248

1.4. Solvency of GSK plc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of GSK plc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare GSK plc to Other industry mean.
  • A Debt to Asset Ratio of 0.75 means that GSK plc assets are financed with 74.6% credit (debt) and the remaining percentage (100% - 74.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of GSK plc:

  • The MRQ is 0.746. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.737. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.746TTM0.737+0.009
TTM0.737YOY0.734+0.003
TTM0.7375Y0.776-0.039
5Y0.77610Y0.7760.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7460.562+0.184
TTM0.7370.583+0.154
YOY0.7340.586+0.148
5Y0.7760.583+0.193
10Y0.7760.576+0.200
1.4.2. Debt to Equity Ratio

Measures if GSK plc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare GSK plc to the Other industry mean.
  • A Debt to Equity ratio of 405.6% means that company has €4.06 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of GSK plc:

  • The MRQ is 4.056. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.932. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.056TTM3.932+0.124
TTM3.932YOY3.938-0.006
TTM3.9325Y5.967-2.035
5Y5.96710Y5.9670.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0561.244+2.812
TTM3.9321.337+2.595
YOY3.9381.370+2.568
5Y5.9671.439+4.528
10Y5.9671.455+4.512

2. Market Valuation of GSK plc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings GSK plc generates.

  • Above 15 is considered overpriced but always compare GSK plc to the Other industry mean.
  • A PE ratio of 69.21 means the investor is paying €69.21 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of GSK plc:

  • The EOD is 64.832. Neutral. Compare to industry.
  • The MRQ is 69.208. Neutral. Compare to industry.
  • The TTM is 52.861. Good. +1
Trends
Current periodCompared to+/- 
EOD64.832MRQ69.208-4.376
MRQ69.208TTM52.861+16.347
TTM52.861YOY51.830+1.031
TTM52.8615Y38.631+14.230
5Y38.63110Y38.6310.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD64.83236.308+28.524
MRQ69.20838.458+30.750
TTM52.86144.588+8.273
YOY51.83048.072+3.758
5Y38.63140.090-1.459
10Y38.63141.443-2.812
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of GSK plc.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of GSK plc:

  • The MRQ is -58.975. Very Bad. -2
  • The TTM is -84.701. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-58.975TTM-84.701+25.726
TTM-84.701YOY18.331-103.032
TTM-84.7015Y10.024-94.725
5Y10.02410Y10.0240.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-58.9750.154-59.129
TTM-84.7010.050-84.751
YOY18.3310.186+18.145
5Y10.0240.158+9.866
10Y10.0240.155+9.869

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of GSK plc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 2.56 means the investor is paying €2.56 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of GSK plc:

  • The EOD is 2.400. Good. +1
  • The MRQ is 2.562. Good. +1
  • The TTM is 2.408. Good. +1
Trends
Current periodCompared to+/- 
EOD2.400MRQ2.562-0.162
MRQ2.562TTM2.408+0.153
TTM2.408YOY2.500-0.092
TTM2.4085Y2.121+0.287
5Y2.12110Y2.1210.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD2.4001.411+0.989
MRQ2.5621.419+1.143
TTM2.4081.575+0.833
YOY2.5001.352+1.148
5Y2.1211.288+0.833
10Y2.1211.330+0.791
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of GSK plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0670.060-213%0.391-117%0.588-111%0.588-111%
Book Value Growth---0.038-0.026-31%-0.020-46%0.035-208%0.035-208%
Book Value Per Share--6.4716.363+2%5.169+25%4.266+52%4.266+52%
Book Value Per Share Growth---0.0100.009-217%0.065-116%0.125-108%0.125-108%
Current Ratio--1.4321.057+35%0.886+62%0.904+58%0.904+58%
Debt To Asset Ratio--0.7460.737+1%0.734+2%0.776-4%0.776-4%
Debt To Equity Ratio--4.0563.932+3%3.938+3%5.967-32%5.967-32%
Dividend Per Share--0.3300.289+14%0.247+34%0.259+28%0.259+28%
Dividend Per Share Growth--0.168-0.010+106%0.033+414%0.026+542%0.026+542%
Eps--0.2400.328-27%0.274-13%0.257-7%0.257-7%
Eps Growth---1.174-0.336-71%-0.227-81%-0.071-94%-0.071-94%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.1210.128-6%0.135-10%0.147-18%0.147-18%
Operating Margin----0%0.179-100%0.177-100%0.177-100%
Operating Ratio--1.1581.149+1%1.188-3%1.165-1%1.165-1%
Pb Ratio2.400-7%2.5622.408+6%2.500+2%2.121+21%2.121+21%
Pe Ratio64.832-7%69.20852.861+31%51.830+34%38.631+79%38.631+79%
Peg Ratio---58.975-84.701+44%18.331-422%10.024-688%10.024-688%
Price Per Share15.528-7%16.57615.329+8%12.802+29%14.495+14%14.495+14%
Price To Total Gains Ratio59.031-7%63.01657.033+10%35.835+76%41.035+54%41.035+54%
Profit Growth---123.250-38.075-69%-31.248-75%-16.398-87%-16.398-87%
Quick Ratio--0.1720.313-45%0.315-45%0.304-43%0.304-43%
Return On Assets--0.0090.013-30%0.014-32%0.016-40%0.016-40%
Return On Equity--0.0510.072-29%0.074-31%0.114-55%0.114-55%
Revenue Growth---0.465-0.098-79%-0.029-94%-0.057-88%-0.057-88%
Total Gains Per Share--0.2630.348-25%0.639-59%0.847-69%0.847-69%
Total Gains Per Share Growth---1.471-1.513+3%0.186-890%-1.301-12%-1.301-12%
Usd Book Value--27324385800.00026661190128.750+2%25351393764.375+8%22015027292.143+24%22015027292.143+24%
Usd Book Value Change Per Share---0.0700.062-213%0.406-117%0.611-111%0.611-111%
Usd Book Value Per Share--6.7186.606+2%5.366+25%4.429+52%4.429+52%
Usd Dividend Per Share--0.3430.300+14%0.257+34%0.269+28%0.269+28%
Usd Eps--0.2490.341-27%0.284-13%0.267-7%0.267-7%
Usd Price Per Share16.121-7%17.20915.914+8%13.291+29%15.049+14%15.049+14%
Usd Profit--1011388485.0001374969369.375-26%1324279254.375-24%1501651553.036-33%1501651553.036-33%
Usd Revenue--8362662067.50010654881136.875-22%9925305553.125-16%10230782462.143-18%10230782462.143-18%
Usd Total Gains Per Share--0.2730.362-25%0.663-59%0.879-69%0.879-69%
 EOD+3 -2MRQTTM+10 -24YOY+11 -245Y+13 -2210Y+13 -22

3.2. Fundamental Score

Let's check the fundamental score of GSK plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1564.832
Price to Book Ratio (EOD)Between0-12.400
Net Profit Margin (MRQ)Greater than00.121
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.172
Current Ratio (MRQ)Greater than11.432
Debt to Asset Ratio (MRQ)Less than10.746
Debt to Equity Ratio (MRQ)Less than14.056
Return on Equity (MRQ)Greater than0.150.051
Return on Assets (MRQ)Greater than0.050.009
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of GSK plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.475
Ma 20Greater thanMa 5015.269
Ma 50Greater thanMa 10016.450
Ma 100Greater thanMa 20016.862
OpenGreater thanClose15.406
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in GBP. All numbers in thousands.

Summary
Total Assets89,045,000
Total Liabilities66,405,000
Total Stockholder Equity16,374,000
 As reported
Total Liabilities 66,405,000
Total Stockholder Equity+ 16,374,000
Total Assets = 89,045,000

Assets

Total Assets89,045,000
Total Current Assets54,188,000
Long-term Assets54,188,000
Total Current Assets
Cash And Cash Equivalents 6,465,000
Short-term Investments 67,000
Net Receivables 6,457,000
Inventory 4,664,000
Total Current Assets  (as reported)54,188,000
Total Current Assets  (calculated)17,653,000
+/- 36,535,000
Long-term Assets
Goodwill 5,906,000
Intangible Assets 11,371,000
Long-term Assets Other 1,736,000
Long-term Assets  (as reported)34,857,000
Long-term Assets  (calculated)19,013,000
+/- 15,844,000

Liabilities & Shareholders' Equity

Total Current Liabilities37,835,000
Long-term Liabilities28,570,000
Total Stockholder Equity16,374,000
Total Current Liabilities
Accounts payable 14,806,000
Other Current Liabilities 888,000
Total Current Liabilities  (as reported)37,835,000
Total Current Liabilities  (calculated)15,694,000
+/- 22,141,000
Long-term Liabilities
Long-term Liabilities Other 6,353,000
Long-term Liabilities  (as reported)28,570,000
Long-term Liabilities  (calculated)6,353,000
+/- 22,217,000
Total Stockholder Equity
Retained Earnings 9,824,000
Total Stockholder Equity (as reported)16,374,000
Total Stockholder Equity (calculated)9,824,000
+/- 6,550,000
Other
Capital Stock1,347,000
Common Stock Shares Outstanding 4,067,321
Net Invested Capital 16,374,000
Net Working Capital 16,353,000



Balance Sheet

Currency in GBP. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
62,365,000
63,632,000
83,245,000
79,692,000
84,382,000
84,640,000
80,927,000
80,431,000
78,079,000
77,011,000
78,689,000
79,103,000
89,689,000
89,045,000
89,045,00089,689,00079,103,00078,689,00077,011,00078,079,00080,431,00080,927,00084,640,00084,382,00079,692,00083,245,00063,632,00062,365,000
   > Total Current Assets 
17,524,000
18,228,000
20,990,000
19,491,000
22,023,000
22,978,000
19,881,000
20,247,000
18,524,000
17,566,000
18,254,000
18,674,000
28,988,000
54,188,000
54,188,00028,988,00018,674,00018,254,00017,566,00018,524,00020,247,00019,881,00022,978,00022,023,00019,491,00020,990,00018,228,00017,524,000
       Cash And Cash Equivalents 
4,132,000
4,123,000
4,305,000
4,707,000
4,769,000
8,166,000
4,283,000
6,092,000
4,757,000
3,503,000
3,453,000
4,074,000
10,967,000
6,465,000
6,465,00010,967,0004,074,0003,453,0003,503,0004,757,0006,092,0004,283,0008,166,0004,769,0004,707,0004,305,0004,123,0004,132,000
       Short-term Investments 
81,000
84,000
86,000
79,000
86,000
87,000
83,000
78,000
60,000
59,000
61,000
61,000
3,010,000
67,000
67,0003,010,00061,00061,00059,00060,00078,00083,00087,00086,00079,00086,00084,00081,000
       Net Receivables 
6,551,000
6,875,000
8,173,000
5,487,000
8,530,000
7,168,000
7,854,000
5,549,000
6,492,000
6,902,000
7,697,000
6,246,000
8,300,000
6,457,000
6,457,0008,300,0006,246,0007,697,0006,902,0006,492,0005,549,0007,854,0007,168,0008,530,0005,487,0008,173,0006,875,0006,551,000
       Inventory 
5,678,000
5,959,000
6,776,000
5,947,000
5,952,000
6,396,000
6,440,000
5,996,000
6,216,000
6,330,000
6,244,000
5,783,000
6,003,000
4,664,000
4,664,0006,003,0005,783,0006,244,0006,330,0006,216,0005,996,0006,440,0006,396,0005,952,0005,947,0006,776,0005,959,0005,678,000
   > Long-term Assets 
44,841,000
45,404,000
62,255,000
60,201,000
62,359,000
61,662,000
61,046,000
60,184,000
59,555,000
59,445,000
60,435,000
60,429,000
60,701,000
34,857,000
34,857,00060,701,00060,429,00060,435,00059,445,00059,555,00060,184,00061,046,00061,662,00062,359,00060,201,00062,255,00045,404,00044,841,000
       Goodwill 
6,807,000
7,026,000
11,046,000
10,562,000
10,899,000
10,998,000
10,888,000
10,597,000
10,442,000
10,435,000
10,582,000
10,552,000
10,705,000
5,906,000
5,906,00010,705,00010,552,00010,582,00010,435,00010,442,00010,597,00010,888,00010,998,00010,899,00010,562,00011,046,0007,026,0006,807,000
       Intangible Assets 
20,022,000
20,134,000
32,455,000
30,955,000
31,499,000
31,263,000
30,664,000
29,824,000
29,418,000
29,333,000
30,241,000
30,079,000
30,468,000
11,371,000
11,371,00030,468,00030,079,00030,241,00029,333,00029,418,00029,824,00030,664,00031,263,00031,499,00030,955,00032,455,00020,134,00020,022,000
       Long-term Assets Other 
1,352,000
1,393,000
1,058,000
1,020,000
2,037,000
946,000
932,000
1,041,000
989,000
1,136,000
1,245,000
1,676,000
1,806,000
1,736,000
1,736,0001,806,0001,676,0001,245,0001,136,000989,0001,041,000932,000946,0002,037,0001,020,0001,058,0001,393,0001,352,000
> Total Liabilities 
58,994,000
60,665,000
65,185,000
61,335,000
64,285,000
64,503,000
60,302,000
59,623,000
57,069,000
55,433,000
56,941,000
57,761,000
67,057,000
66,405,000
66,405,00067,057,00057,761,00056,941,00055,433,00057,069,00059,623,00060,302,00064,503,00064,285,00061,335,00065,185,00060,665,00058,994,000
   > Total Current Liabilities 
24,460,000
25,779,000
25,514,000
24,050,000
25,335,000
23,924,000
22,179,000
22,148,000
20,275,000
21,387,000
22,417,000
23,670,000
24,278,000
37,835,000
37,835,00024,278,00023,670,00022,417,00021,387,00020,275,00022,148,00022,179,00023,924,00025,335,00024,050,00025,514,00025,779,00024,460,000
       Short-term Debt 
0
0
0
6,678,000
0
0
0
0
0
0
0
0
0
0
00000000006,678,000000
       Short Long Term Debt 
0
0
0
6,678,000
0
492,000
0
3,495,000
0
0
0
3,398,000
0
0
003,398,0000003,495,0000492,00006,678,000000
       Accounts payable 
13,424,000
13,385,000
14,737,000
4,144,000
15,310,000
15,450,000
15,142,000
4,357,000
14,610,000
14,267,000
15,230,000
4,535,000
17,577,000
14,806,000
14,806,00017,577,0004,535,00015,230,00014,267,00014,610,0004,357,00015,142,00015,450,00015,310,0004,144,00014,737,00013,385,00013,424,000
       Other Current Liabilities 
830,000
816,000
838,000
755,000
796,000
804,000
776,000
765,000
746,000
743,000
765,000
958,000
971,000
888,000
888,000971,000958,000765,000743,000746,000765,000776,000804,000796,000755,000838,000816,000830,000
   > Long-term Liabilities 
34,534,000
34,886,000
39,671,000
37,285,000
38,950,000
40,579,000
38,123,000
37,475,000
36,794,000
34,046,000
34,524,000
34,091,000
42,779,000
28,570,000
28,570,00042,779,00034,091,00034,524,00034,046,00036,794,00037,475,00038,123,00040,579,00038,950,00037,285,00039,671,00034,886,00034,534,000
       Capital Lease Obligations Min Short Term Debt
0
0
0
-5,428,000
0
0
0
1,117,000
0
0
0
1,015,000
0
0
001,015,0000001,117,000000-5,428,000000
       Long-term Liabilities Other 
6,006,000
6,090,000
6,172,000
4,724,000
5,673,000
5,854,000
6,118,000
5,104,000
5,846,000
5,826,000
5,872,000
5,118,000
6,095,000
6,353,000
6,353,0006,095,0005,118,0005,872,0005,826,0005,846,0005,104,0006,118,0005,854,0005,673,0004,724,0006,172,0006,090,0006,006,000
> Total Stockholder Equity
4,014,000
3,614,000
11,772,000
11,405,000
13,094,000
13,593,000
14,286,000
14,587,000
14,865,000
15,377,000
15,426,000
15,055,000
16,181,000
16,374,000
16,374,00016,181,00015,055,00015,426,00015,377,00014,865,00014,587,00014,286,00013,593,00013,094,00011,405,00011,772,0003,614,0004,014,000
   Common Stock00000000000000
   Retained Earnings Total Equity00000000000000
   Accumulated Other Comprehensive Income 00000000000000
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 00000000000000



Balance Sheet

Currency in GBP. All numbers in thousands.




Cash Flow

Currency in GBP. All numbers in thousands.




Income Statement

Currency in GBP. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue34,114,000
Cost of Revenue-11,603,000
Gross Profit22,511,00022,511,000
 
Operating Income (+$)
Gross Profit22,511,000
Operating Expense-27,431,000
Operating Income6,683,000-4,920,000
 
Operating Expense (+$)
Research Development5,278,000
Selling General Administrative10,975,000
Selling And Marketing Expenses-
Operating Expense27,431,00016,253,000
 
Net Interest Income (+$)
Interest Income26,000
Interest Expense-777,000
Net Interest Income-754,000-751,000
 
Pretax Income (+$)
Operating Income6,683,000
Net Interest Income-754,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)5,442,0006,683,000
EBIT - interestExpense = -777,000
4,385,000
5,162,000
Interest Expense777,000
Earnings Before Interest and Taxes (ebit)-6,219,000
Earnings Before Interest and Taxes (ebitda)8,596,000
 
After tax Income (+$)
Income Before Tax5,442,000
Tax Provision-346,000
Net Income From Continuing Ops5,096,0005,096,000
Net Income4,385,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-754,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
MXG.TO
now

I found you a Death Cross on the daily chart of MXG.TO.

MXG.TO Daily Candlestick Chart
ZDM.TO
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ZDM.TO.

ZDM.TO Daily Candlestick Chart
TIXT.TO
9 minutes ago

I found you a Death Cross on the daily chart of TIXT.TO.

TIXT.TO Daily Candlestick Chart
ZORDIX-B.ST
14 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ZORDIX-B.ST.

ZORDIX-B.ST Daily Candlestick Chart
RCSL3.SA
17 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RCSL3.SA.

RCSL3.SA Daily Candlestick Chart
POSI3.SA
17 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of POSI3.SA.

POSI3.SA Daily Candlestick Chart
PETR3.SA
17 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PETR3.SA.

PETR3.SA Daily Candlestick Chart
LREN3.SA
19 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of LREN3.SA.

LREN3.SA Daily Candlestick Chart
HGRE11.SA
19 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HGRE11.SA.

HGRE11.SA Daily Candlestick Chart
HAPV3.SA
20 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HAPV3.SA.

HAPV3.SA Daily Candlestick Chart
JAX.V
27 minutes ago

I found you a MACD Bearish Hidden Divergence on the daily chart of JAX.V.

JAX.V Daily Candlestick Chart
OLY.TO
28 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OLY.TO.

OLY.TO Daily Candlestick Chart
ILSPLN.FOREX
3 hours ago

I found you a Death Cross on the daily chart of ILSPLN.FOREX.

ILSPLN.FOREX Daily Candlestick Chart
MYRCNH.FOREX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MYRCNH.FOREX.

MYRCNH.FOREX Daily Candlestick Chart
CNHTWD.FOREX
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CNHTWD.FOREX.

CNHTWD.FOREX Daily Candlestick Chart
MCRNT.TA
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of MCRNT.TA.

MCRNT.TA Daily Candlestick Chart
TTAM.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TTAM.TA.

TTAM.TA Daily Candlestick Chart
TPGM.TA
9 hours ago

I found you a Death Cross on the daily chart of TPGM.TA.

TPGM.TA Daily Candlestick Chart
SNCM.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SNCM.TA.

SNCM.TA Daily Candlestick Chart
SCOP.TA
9 hours ago

I found you a Death Cross on the daily chart of SCOP.TA.

SCOP.TA Daily Candlestick Chart
SALG.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SALG.TA.

SALG.TA Daily Candlestick Chart
OPK.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of OPK.TA.

OPK.TA Daily Candlestick Chart
KMDA.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of KMDA.TA.

KMDA.TA Daily Candlestick Chart
MIFT.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MIFT.TA.

MIFT.TA Daily Candlestick Chart
DIFI.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DIFI.TA.

DIFI.TA Daily Candlestick Chart